Background Risk stratification for transcatheter edge-to-edge mitral valve repair (TEER) is
paramount in the decision-making process for treating severe mitral regurgitation (MR) …

Background Data on the efficacy of transcatheter edge-to-edge repair (TEER) in patients
with cardiogenic shock (CS) are limited. Objectives This study investigated the …

Mitral regurgitation (MR) is the most prevalent valvular heart disease and, when left
untreated, results in reduced quality of life, heart failure, and increased mortality. Mitral valve …

Background There are limited data on the predictors of death or heart failure hospitalization
(HFH) in patients with heart failure (HF) with functional mitral regurgitation (FMR). Objectives …

Background The outcomes after mitral valve transcatheter edge-to-edge repair (M-TEER) for
the patients with severe mitral regurgitation (MR) in hemodynamically unstable conditions …

Background A risk score was recently derived from the Cardiovascular Outcomes
Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with …

Aim Diabetes mellitus (DM) represents a notable risk factor within surgical and interventional
procedures. Data on its influence on survival after Transcatheter Edge-to-Edge Repair …

Objectives Transcatheter edge-to-edge repair (TEER) is an alternative for patients with
severe degenerative mitral regurgitation (MR). The objective of this study was to compare …

目的探讨慢性阻塞性肺疾病(COPD) 合并慢性心力衰竭(CHF) 评估模型对患者预后的预测价值.
方法采用回顾性研究方法. 选择2016 年6 月至2019 年6 月河北北方学院附属第一医院收治的94 …

The incidence of valvular heart disease is 64 per 100,000 person-years in the United States,
with almost 24.2% of all valve diagnoses being mitral regurgitation (MR). Around 16,250 …